Drugs / A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca)
A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca)
also known as
H2N3 MO 2006/AA ca
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01674205 | Sep 2012 → Jun 2013 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01674205 ↗ |
| Known as | H2N3 MO 2006/AA ca | “A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca)” NCT01674205 ↗ |
| Modality | Vaccine | “candidate pandemic live attenuated influenza vaccine (LAIV)” NCT01674205 ↗ |
| Route | Intranasal | “0.2 mL being delivered by Accuspray device (0.1 mL per nostril)” NCT01674205 ↗ |